Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Minoxidil affects collagen-related genes, potentially helping treat fibrosis.

Mixed coconut oil/solvent is suitable for cyproterone acetate injections, but more safety checks are needed.

Baicalin may help reduce excessive male hormone levels in PCOS.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

Neurosteroids may help treat disorders with too much dopamine activity.

Testosterone, 4-hydroxyandrostenedione, and finasteride affect blood clotting differently in stressed heart conditions.

Vitex negundo has potential health benefits, including anti-inflammatory and anti-cancer effects.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Finasteride reduces alcohol withdrawal severity and anxiety in mice, but may increase withdrawal severity in some cases.

Baricitinib is more effective than methotrexate for severe alopecia areata.

The combination of spironolactone and low-dose minoxidil is generally safe for treating hair loss in adult females, with mostly mild side effects.

Freeze-dried dexamethasone nanoparticles in a hydrogel are stable and effective for treating alopecia areata.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

Ozenoxacin reduces sebum production, helping manage acne.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

A postmenopausal woman's hormone imbalance and symptoms improved after removing benign ovarian tumors.

The document is retracted and cannot be summarized.

Synthetic hormone treatment reduces melanin and hair growth in rats.